Optimal timing of combining sorafenib with trans-arterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis

Authors:

Abstract
No abstract available
Funding Information
  • National Key Research and Development Program of China Stem Cell and Translational Research (2019YFC0118100)
  • National Natural Science Foundation of China (81671760, 81873910)
  • National Key Research and Development Program of China

This publication has 30 references indexed in Scilit: